From the Department of Medicine, Hackensack University-Palisades Medical Center, North Bergen, NJ.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Pancreas. 2020 May/Jun;49(5):612-620. doi: 10.1097/MPA.0000000000001550.
Despite extensive research in the pathogenesis, early detection, and therapeutic approaches of pancreatic ductal adenocarcinoma (PDAC), it remains a devastating and incurable disease. As the global incidence and prevalence of PDAC continue to rise, there is a pressing need to place strong emphasis on its prevention. Although it is widely recognized that cigarette smoking, a potentially modifiable risk factor, has been linked to PDAC development, its contribution to prognosis is still uncertain. Moreover, the mechanistic pathways of PDAC progression secondary to smoking are various and lack a summative narration. Herein, we update and summarize the direct and indirect roles cigarette smoking plays on PDAC development, review literature to conclude the impact cigarette smoking has on prognosis, and postulate a comprehensive mechanism for cigarette smoking-induced PDAC.
尽管在胰腺导管腺癌(PDAC)的发病机制、早期检测和治疗方法方面进行了广泛的研究,但它仍然是一种毁灭性的、无法治愈的疾病。随着 PDAC 的全球发病率和患病率持续上升,迫切需要高度重视其预防。尽管人们普遍认识到,可改变的风险因素之一——吸烟,与 PDAC 的发生有关,但吸烟对其预后的影响仍不确定。此外,吸烟导致 PDAC 进展的机制途径多种多样,缺乏综合叙述。在此,我们更新并总结了吸烟对 PDAC 发生的直接和间接作用,回顾文献得出吸烟对预后的影响,并提出了一个吸烟诱导 PDAC 的综合机制。